PMV Pharmaceuticals, Inc. - COMMON STOCK (PMVP)

CUSIP: 69353Y103

Q4 2021 13F Holders as of 31 Dec 2021

Type / Class
Equity / COMMON STOCK
Shares outstanding
53,185,766
Total 13F shares
47,470,437
Share change
+1,136,682
Total reported value
$1,096,597,184
Price per share
$23.10
Number of holders
102
Value change
+$15,190,740
Number of buys
62
Number of sells
31

Quarterly Holders Quick Answers

What is CUSIP 69353Y103?
CUSIP 69353Y103 identifies PMVP - PMV Pharmaceuticals, Inc. - COMMON STOCK in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of PMV Pharmaceuticals, Inc. - COMMON STOCK (PMVP) as of Q4 2021

As of 31 Dec 2021, PMV Pharmaceuticals, Inc. - COMMON STOCK (PMVP) was held by 102 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 47,470,437 shares. The largest 10 holders included ORBIMED ADVISORS LLC, INTERWEST VENTURE MANAGEMENT CO, JPMORGAN CHASE & CO, RTW INVESTMENTS, LP, BOXER CAPITAL, LLC, VANGUARD GROUP INC, BlackRock Inc., Euclidean Capital LLC, VIKING GLOBAL INVESTORS LP, and RA CAPITAL MANAGEMENT, L.P.. This page lists 102 institutional shareholders reporting positions in this security for the Q4 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.